Indefinite Delivery Contract SPE2DU25D4314
- Not listed
- The Indefinite Delivery Contract (IDC) SPE2DR25D3012 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, which runs through December 2026, establishes AmerisourceBergen as a Pharmaceutical Prime Vendor to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally....
- The Indefinite Delivery Contract (IDC) SPE2DR25D1102 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
- The Indefinite Delivery Contract (IDC) SPE2DR25D1110 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, is an unrestricted, fully competitive acquisition that aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including...
- The Indefinite Delivery Contract (IDC) SPE2DR25D3026, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $9.99 billion single-award contract to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses a 30-month base period with three 30-month option periods, running through December 2036. As the prime vendor, Amerisourcebergen will be...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9.99 billion contract, which runs through December 2036, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet....
- The Indefinite Delivery Contract (IDC) SPE2DR25D2206 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast...
- The Indefinite Delivery Contract (IDC) SPE2DR25D1041 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC has a period of performance from August 1, 2025 to December 31, 2036, and supports DLA, the Department of Defense (DoD), the U.S. Coast Guard, and other government agencies by providing a comprehensive range of pharmaceutical products...
- The federal Indefinite Delivery Contract (IDC) SPE2DU25D5323, awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $9,999,999,999 single-award IDC, with a period of performance through December 2036, serves as a prime vendor contract vehicle for delivering brand-name and generic drugs, specialty...
- The Indefinite Delivery Contract (IDC) SPE2DR25D1004 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The...
- The Indefinite Delivery Contract (IDC) SPE2DR25D7005 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $999,999,999.00. The contract, which runs through December 2036, provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. Amerisourcebergen will be...
The Indefinite Delivery Contract (IDC) SPE2DU25D4314 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9.99 billion contract, which runs through December 2036, establishes a Prime Vendor program to provide worldwide pharmaceutical support to the Department of Defense (DoD), United States Coast Guard, and other government agencies. The contract covers the full range of pharmaceutical products, including brand-name and generic drugs, specialty medications, vaccines, medical devices, and related supplies across multiple therapeutic areas. Amerisourcebergen will serve as the primary supplier for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, while also providing backup supplier services. The contract enables efficient government procurement of essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism. This unrestricted, fully competitive acquisition was awarded based on the lowest overall price considering distribution fees for brand/generic and specialty pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/7/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global GEN V Presolicitation | SPE2DX-24-R-0001 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/5 | 2/1/24, 3:44 PM | |
Pharmaceutical Prime Vendor Global GEN V Solicitation | SPE2DX-24-R-0001_SOLICITATION | Defense Logistics Agency Troop Support Medical | Solicitation 2/5 | 3/13/24, 11:08 AM | |
PPVG GEN V Award | SPE2DX-25-D-1000 | Defense Logistics Agency Troop Support Medical | Award Notice 3/5 | 3/7/25, 10:09 AM | |
PPVG GEN V AWARD SPE2DX25D9000 | SPE2DX25D9000 | Defense Logistics Agency Troop Support Medical | Award Notice 4/5 | 3/7/25, 10:14 AM | |
PPVG GEN V AWARD SPE2DX25D8000 | SPE2DX25D8000 | Defense Logistics Agency Troop Support Medical | Award Notice 5/5 | 3/7/25, 10:18 AM |